Procedure for Determining Shelf Life of Parenteral Drug Products
1) Purpose
The purpose of this SOP is to provide a standardized procedure for determining the shelf life of parenteral drug products through stability studies under various environmental conditions.
2) Scope
This SOP applies to all parenteral drug products that require stability testing to determine their shelf life and storage requirements. It is relevant for personnel in quality control, research and development, and regulatory affairs departments.
3) Responsibilities
The responsibilities for determining the shelf life of parenteral products are as follows:
- Quality Control Team: To perform stability tests
as per the protocol and document results.
R&D Team: To design the stability study protocol and provide technical support.
Regulatory Affairs Team: To ensure compliance with regulatory guidelines during stability testing.
Stability Study Coordinator: To manage testing schedules, sample management, and data analysis.
for determining the shelf life of parenteral products is outlined below:
4) Procedure
The detailed stepwise procedure
- Preparation of Stability Study Protocol:
- 4.1 Define the purpose, scope, and objective of the stability study for parenteral products.
- 4.2 Identify the parenteral drug product and critical quality attributes (CQAs) to be monitored (e.g., sterility, potency, degradation products).
- 4.3 Determine the storage conditions to be tested (e.g., refrigerated, room temperature).
- 4.4 Establish the time points for testing at each storage condition (e.g., 0, 3, 6, 12, 24 months).
- 4.5 Develop a protocol outlining procedures, equipment, and materials required for testing.
- Sample Preparation and Storage:
- 4.6 Select representative samples of the parenteral product for testing.
- 4.7 Prepare and package samples in their final storage configuration.
- 4.8 Store samples under specified conditions in stability chambers or other controlled environments.
- Testing and Monitoring:
- 4.9 Retrieve samples at specified time points and perform the required tests (e.g., sterility, assay, degradation products).
- 4.10 Record all test results in a stability testing log sheet.
- 4.11 Evaluate the results against predefined acceptance criteria.
- Data Analysis and Interpretation:
- 4.12 Analyze the stability data to identify any trends or deviations in the quality attributes.
- 4.13 Determine the shelf life of the parenteral product based on stability data.
- 4.14 Document any significant findings or trends in the data.
- Documentation and Reporting:
- 4.15 Compile a comprehensive stability study report including objectives, methods, results, and conclusions.
- 4.16 Ensure the report is reviewed and approved by relevant stakeholders.
- 4.17 Submit the report to regulatory bodies or internal stakeholders as required.
- Review and Update:
- 4.18 Regularly review the stability study protocol and update it based on new data or regulatory changes.
- 4.19 Archive the approved protocol and report in a controlled document management system.
5) Abbreviations, if any
- CQA: Critical Quality Attribute
6) Documents, if any
- Parenteral Product Stability Study Protocol
- Stability Testing Log Sheets
- Stability Study Report Template
7) Reference, if any
- ICH Q1A(R2): Stability Testing of New Drug Substances and Products
8) SOP Version
Version 1.0